AGP Picks
View all

Fintech World Post: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Fintech World Post.

Press releases published on October 5, 2026

Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
NanoXplore Announces the Creation of an Advisory Board for Its Subsidiary VoltaXplore and Appoints Galvion Founder and Executive Chairman Jonathan Blanshay as Inaugural Member
NanoXplore annonce la création d’un Conseil consultatif pour sa filiale VoltaXplore et nomme Jonathan Blanshay, fondateur et président exécutif de Galvion, à titre de membre inaugural
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update
CTW to Announce Fiscal Year 2026 Financial Results on October 15 and Host Earnings Webinar on October 16
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
Polar Power Rejects Solidion All-Cash Offer for Company Assets
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
Leonardo DRS Completes Training and Delivery of INOD Block III Thermal Weapon Sights for the Australian Army
Premium Income Corporation  Announces Monthly Distribution
Mulvihill Enhanced Split Preferred Share ETF  Declares Monthly Distribution
Mulvihill Split Capital Share ETF Declares Monthly Distribution
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
Mulvihill Canadian Bank ETF Declares Monthly Distribution
Premium Global Income Split Fund Declares Monthly Distribution
Mulvihill Split Preferred Share ETF Declares Monthly Distribution
Mulvihill Premium Yield Declares Monthly Fund Distribution for Its ETF Class
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Fintech World Post

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.